Evidence map›Paper›PMID 41776291›Full record

ArticleNpj biological timing and sleep2026

Naturalistic light exposure patterns in relation to medication status, mood symptoms, and chronotype.

Rebecca J Fitton, Julia E Stone, Alicia C Lander, Melisa Hrnjic, Malisa T Burge, Elizabeth J Buller, Amber P White, Andrew J K Phillips, Sean W Cain, Elise M McGlashan

Abstract read
In one paragraph

Article in Npj biological timing and sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca J FittonSchool of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia.
Julia E StoneMelbourne School of Psychological Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Alicia C LanderAdelaide Institute for Sleep Health, Flinders Health and Medical Research Institute (Sleep Health), Flinders University, Adelaide, SA, Australia.
Melisa HrnjicSchool of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia.
Malisa T BurgeSchool of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia.
Elizabeth J BullerSchool of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia.
Amber P WhiteOrygen, Parkville, VIC, Australia.
Andrew J K PhillipsAdelaide Institute for Sleep Health, Flinders Health and Medical Research Institute (Sleep Health), Flinders University, Adelaide, SA, Australia.
Sean W Cain *Adelaide Institute for Sleep Health, Flinders Health and Medical Research Institute (Sleep Health), Flinders University, Adelaide, SA, Australia. sean.cain@flinders.edu.au.
Elise M McGlashan *School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia. elise.mcglashan@unimelb.edu.au.

Funding

Australian Research Council 220102812Beacon Lighting NANational Health and Medical Research Council 1183472
6 · The paper itself

Abstract

Light assists in regulating mood, and selective serotonin reuptake inhibitors (SSRIs) increase non-visual light sensitivity. It remains unclear whether light exposure patterns differ between individuals taking SSRIs compared to unmedicated individuals with no psychiatric history, or how everyday light exposure relates to mood and chronotype. This study examined objective light exposure (melanopic EDI) in relation to medication status (SSRI vs. control), mood symptoms, and chronotype. Participants (n = 76; 38 SSRIs, 38 controls) completed at least one week of field light monitoring using a wearable sensor and questionnaires assessing mood (DASS-21) and chronotype (MEQ). Overall light exposure did not differ between groups. However, when accounting for group, greater morning light exposure was associated with lower depressive and stress symptoms, and more time spent above 50 melanopic EDI was associated with fewer depressive symptoms. Greater morningness was linked to higher morning and daytime melanopic EDI, more time in bright light (>50 and >250 melanopic EDI), and differences in light regularity. These findings show that light exposure, particularly its timing and amount, relates to mood and chronotype, regardless of SSRI use. Future research targeting light behaviour may offer an accessible, cost-effective strategy for improving mood in both clinical and non-clinical populations.

Identifiers

PMID41776291
PMCPMC12912433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.